The RIDU antimicrobial management team have recently had 3 abstracts published in JAC-AMR, in Volume 6, Issue Supplement_2, August 2024.

All abstracts review and aim to guide and improve clinical practice in some way. Antimicrobial medicine, an aspect of modern medicine that healthcare relies on, is threatened by the emergence and spread of drug-resistant pathogens.

With antimicrobial resistance (AMR) on the rise, alongside it’s associated and subsequent complications, there grows the importance for managing AMR both locally and globally, & the importance of such research and clinical considerations. Read more on the impact of AMR on the World Health Organisation’s website: Antimicrobial resistance (who.int)

The abstracts:

• Clinical perceptions of the need for anaerobic coverage in patients treated for aspiration pneumonia
  P12 Clinical perceptions of the need for anaerobic coverage in patients treated for aspiration pneumonia (AP) | JAC-Antimicrobial Resistance | Oxford Academic (oup.com)
• How do we improve gentamicin prescribing and reviewing within colorectal wards—a quality improvement project
  P22 How do we improve gentamicin prescribing and reviewing within colorectal wards—a quality improvement project | JAC-Antimicrobial Resistance | Oxford Academic (oup.com)
• An observational prospective audit on the use of vancomycin and ciprofloxacin in the treatment of severe community-acquired pneumonia in penicillin-allergic patients in NHS Lothian
  P31 An observational prospective audit on the use of vancomycin and ciprofloxacin in the treatment of severe community-acquired pneumonia in penicillin-allergic patients in NHS Lothian | JAC-Antimicrobial Resistance | Oxford Academic (oup.com)

Well done to all those involved!